MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-PB-20-0013908
Elfin Drugs Private Limited - pharma in Mohali, Punjab, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹21.23 Cr
▲ 15% YoY
Net profit · FY 2024
₹21.1 Lakh
Net margin 1%
EBITDA · FY 2024
₹1.68 Cr
EBITDA margin 7.9%
Authorised capital
₹75 Lakh
Registered with MCA
Paid-up capital
₹70.51 Lakh
Issued & subscribed
Open charges
₹20.42 Cr
Satisfied ₹18.5 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
19
Provident fund records
About Elfin Drugs Private Limited
Data last updated:
Elfin Drugs Private Limited is a private limited company based in Mohali, Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 April 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24231PB2005PTC028300. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹70.51 Lakh. It is led by directors Dilpreet Singh and Surinder Jit Kaur.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at E – 206 Industrial Area Phase – 8 – B, Mohali, Punjab, India – 160055.
As per the financials filed for FY 2024, the company reported a revenue of ₹21.23 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹21.1 Lakh (net margin 1%) and EBITDA of ₹1.68 Cr (EBITDA margin 7.9%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 18% over five years.
The company has about 19 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Elfin Drugs and Elfin. As per MCA filings, the company has open charges of ₹20.42 Cr and satisfied charges of ₹18.5 Cr on record. Court records list 86 cases involving the company, including 3 filed by the company and 83 filed against it; 54 cases are pending.
Elfin Drugs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-PB-20-0013908). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website elfinpharma.in.
Company details
CIN U24231PB2005PTC028300
Registration Number 028300
Incorporation Date 25 April 2005
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-PB-20-0013908
Recognitions & Rankings of Elfin Drugs
Contact details
Elfin Drugs Private Limited's registered office is in Mohali, Punjab. Its website is elfinpharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressE – 206 Industrial Area Phase – 8 – B, Mohali, Punjab, India – 160055
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Elfin Drugs Private Limited, buy the company report.
Comprehensive company report
Elfin Drugs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Elfin Drugs operates two associated brands: Elfin Drugs and Elfin. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical tablets, capsules, injectables, and syrups for global markets. | elfinpharma.in | |
| Functions as a CDMO specializing in the manufacturing of solid drug formulations. | elfindrugs.com |
Business activity
The main business activity of Elfin Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Elfin Drugs Private Limited, buy the company report.
Financials of Elfin Drugs Private Limited
FY 2024 filings availableElfin Drugs Private Limited reported revenue of ₹21.23 Cr (up 15% YoY) for FY 2024.
Revenue · FY 2024
₹21.23 Cr ▲ 15%
Net profit · FY 2024
₹21.1 Lakh margin 1%
EBITDA · FY 2024
₹1.68 Cr margin 7.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 20%
5 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▲ 30%
3 years · compounded
▲ 17%
5 years · compounded
▲ 18%
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 15% growth in the latest year. EBITDA rose 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹21.23 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.68 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹21.1 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.9% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Elfin Drugs Private Limited, buy the company report.
Board of directors of Elfin Drugs Private Limited
Elfin Drugs has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dilpreet Singh Also directs: Elfin Pharma Private Limited | Director | 25 Apr 2005 | 21 Years 6 Months | Current |
| Surinder Jit Kaur | Director | 19 Jun 2019 | 7 Years 4 Months | Current |
Peer comparison
Elfin Drugs Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ce-Chem Pharmaceuticals Private Limited | ₹21.36 Cr (FY 2025) | 53.0% | Bangalore, Karnataka, India | |||
| Dexbio Pharma Private Limited | ₹21.29 Cr (FY 2025) | 17.0% | Roorkee, Uttarakhand, India | |||
| Dios Lifesciences Private Limited | ₹21.24 Cr (FY 2024) | 44.0% | New Delhi, Delhi, India | |||
| Elfin Drugs Private Limitedthis company | ₹21.23 Cr (FY 2024) | ₹21.1 Lakh | 1% | 15.0% | 19 | Mohali, Punjab, India |
| Marxx Pharma Private Limited | ₹21.23 Cr (FY 2024) | 682.0% | Hisar, Haryana, India | |||
| Ravi Pharmaceuticals Pvt Ltd | ₹21.23 Cr (FY 2024) | 15.0% | Khambhat, Gujarat, India | |||
| Glowsun India Labs Private Limited | ₹21.2 Cr (FY 2024) | 11.0% | Dehradun, Uttarakhand, India | |||
| Ethicare Pharmaceuticals Private Limited | ₹21.2 Cr (FY 2025) | 94.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Elfin Drugs Private Limited, buy the company report.
Auditor
Elfin Drugs Private Limited is audited by R.TREHAN & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R.TREHAN & ASSOCIATES | FY 2024 | 007582N |
Shareholding
The shareholding of Elfin Drugs Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Elfin Drugs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹20.42 Cr
Satisfied charges
₹18.5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Apr 2024 | 100900204 | Bank of India | ₹13.09 Cr | Open | |
| 04 Nov 2022 | 100641947 | Hdfc Bank Limited | ₹15.47 Lakh | Open | |
| 26 Mar 2021 | 100444897 | Hdfc Bank Limited | ₹9 Lakh | Open | |
| 01 Feb 2018 | 100188641 | Others | ₹7 Lakh | Open | |
| 18 Jan 2008 | 10083621 | Oriental Bank of Commerce | ₹5.54 Cr | Open |
To see the full charge records of Elfin Drugs Private Limited, buy the company report.
Total charge records: 14 View all charges
Legal cases
Elfin Drugs Private Limited has 86 court cases on record: 3 filed by Elfin Drugs, 83 filed against it. 54 cases are pending and 32 are disposed.
Total cases
86
Filed by the company
3
Filed against the company
83
Pending
54
Disposed
32
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 82 | 82 | 52 |
| High courts | 4 | 1 | 2 |
Cases on record (5 of 86)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Cheque dishonour complaint | Filed against the company by M/S Signa Medi Solutions Pvt Ltd | Pending |
| District court, Solan, Himachal Pradesh | Cheque dishonour complaint | Filed against the company by M/S Sanchem Sophin Pvt. Ltd. | Pending |
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed against the company by Del Trade International Private Limited | Pending |
| District court, West, Delhi | Commercial suit | Filed against the company by M/S Samchem India Private Limited | Pending |
| District court, Gurugram, Haryana | Cheque dishonour complaint | Filed against the company by Apm Medichem Private Limited | Pending |
To see the full case history of Elfin Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Elfin Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Elfin Drugs Private Limited has a workforce of 19 employees on its EPFO records as of Mar 03, 2025, across 1 active EPFO establishment.
Employee count
19
Active EPFO establishments
1
Employee growth
-17.39%
GST
Elfin Drugs has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
Total GSTINs
2
Cancelled / inactive
2
To see the full GST registrations and return filing status of Elfin Drugs Private Limited, buy the company report.
Recent activity
Elfin Drugs Private Limited has 7 board changes on record since 2005: 2 appointments and 5 cessations. The latest: Rajeev Kumar Singh ceased to be Additional Director on 30 Dec 2020.
AGM
Elfin Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Bank Of India of Rs. 1,309.34 Lakh registered on 18 Apr 2024 with Charge ID 100900204 was modified on 08 Aug 2024.
Charges
A charge with Bank Of India amounted to Rs. 1,309.34 Lakh with Charge ID 100900204 was registered on 18 Apr 2024.
Filing
Elfin Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh.
Charges
A charge registered on 04 Sep 2021 via Charge ID 100498253 with Hdfc Bank Limited was fully satisfied on 01 Feb 2024.
Charges
A charge with Hdfc Bank Limited of Rs. 1,046.10 Lakh registered on 04 Sep 2021 with Charge ID 100498253 was modified on 01 May 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 15.47 Lakh with Charge ID 100641947 was registered on 04 Nov 2022.
Charges
A charge registered on 28 Jun 2016 via Charge ID 100047796 with Others was fully satisfied on 23 Apr 2022.
Charges
A charge registered on 06 Apr 2011 via Charge ID 10286503 with Others was fully satisfied on 08 Nov 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1,046.10 Lakh with Charge ID 100498253 was registered on 04 Sep 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 9.00 Lakh with Charge ID 100444897 was registered on 26 Mar 2021.
Ceased
Rajeev Kumar Singh ceased to be Additional Director.
25 earlier events are in the company report.
Frequently asked questions
Elfin Drugs is an active private limited company based in Mohali, Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 April 2005 (21+ years old) and is registered under CIN U24231PB2005PTC028300.
Elfin Drugs has 2 current directors:
- Dilpreet Singh - Director
- Surinder Jit Kaur - Director
The latest financial statements of Elfin Drugs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
No. Elfin Drugs has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Elfin Drugs is U24231PB2005PTC028300. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Elfin Drugs has 86 court cases on record: 3 filed by the company and 83 filed against it. 54 are pending. Most are in the district courts.
Elfin Drugs was incorporated on 25 April 2005, making it 21+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Elfin Drugs by revenue are Ce-Chem Pharmaceuticals Private Limited, Dexbio Pharma Private Limited, Dios Lifesciences Private Limited, Marxx Pharma Private Limited, Ravi Pharmaceuticals Pvt Ltd and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rajeev Kumar Singh ceased to be Additional Director on 30 Dec 2020. Gurinder Kaur Makkar ceased to be Director on 25 Jun 2020. Manpreet Kaur ceased to be Director on 25 Jun 2020. Elfin Drugs has 7 board changes on record in total.
Yes, Elfin Drugs is registered as a small enterprise under Udyam registration (number: UDYAM-PB-20-0013908).
Elfin Drugs can be reached through the website elfinpharma.in. Its registered office is in Mohali, Punjab, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages